These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35279756)

  • 1. Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
    Dounavi ME; Newton C; Jenkins N; Mak E; Low A; Muniz-Terrera G; Williams GB; Lawlor B; Naci L; Malhotra P; Mackay CE; Koychev I; Ritchie K; Ritchie CW; Su L; O'Brien JT
    J Neurol; 2022 Aug; 269(8):4299-4309. PubMed ID: 35279756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia.
    Dounavi ME; Mak E; Wells K; Ritchie K; Ritchie CW; Su L; O' Brien JT
    Neurobiol Aging; 2020 Jul; 91():36-44. PubMed ID: 32311609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history of Alzheimer's disease and hippocampal structure in healthy people.
    Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
    Am J Psychiatry; 2010 Nov; 167(11):1399-406. PubMed ID: 20686185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.
    Liu X; Dounavi ME; Ritchie K; Wells K; Ritchie CW; Su L; Muniz-Terrera G; O'Brien JT
    J Neurol; 2021 May; 268(5):1962-1971. PubMed ID: 33423129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
    Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
    Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.
    Stephen R; Liu Y; Ngandu T; Rinne JO; Kemppainen N; Parkkola R; Laatikainen T; Paajanen T; Hänninen T; Strandberg T; Antikainen R; Tuomilehto J; Keinänen Kiukaanniemi S; Vanninen R; Helisalmi S; Levälahti E; Kivipelto M; Soininen H; Solomon A
    J Alzheimers Dis; 2017; 59(2):695-705. PubMed ID: 28671114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
    J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
    Low A; Prats-Sedano MA; McKiernan E; Carter SF; Stefaniak JD; Nannoni S; Su L; Dounavi ME; Muniz-Terrera G; Ritchie K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie CW; Markus HS; O'Brien JT
    Alzheimers Res Ther; 2022 Oct; 14(1):154. PubMed ID: 36224605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort.
    Habes M; Toledo JB; Resnick SM; Doshi J; Van der Auwera S; Erus G; Janowitz D; Hegenscheid K; Homuth G; Völzke H; Hoffmann W; Grabe HJ; Davatzikos C
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1636-42. PubMed ID: 27173368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
    Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
    Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of apolipoprotein E4 genotype on cerebro-cerebellar connectivity, brain atrophy, and cognition in patients with Alzheimer's disease.
    de Dieu Uwisengeyimana J; Wang Y; Nguchu BA; Wang X; Qiu B
    J Neurol Sci; 2022 Nov; 442():120435. PubMed ID: 36201963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study.
    Mak E; Dounavi ME; Low A; Carter SF; McKiernan E; Williams GB; Jones PS; Carriere I; Muniz GT; Ritchie K; Ritchie C; Su L; O'Brien JT
    Neuroimage; 2021 Apr; 229():117749. PubMed ID: 33454416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study.
    Régy M; Dugravot A; Sabia S; Fayosse A; Mangin JF; Chupin M; Fischer C; Bouteloup V; Dufouil C; Chêne G; Paquet C; Hanseeuw B; Singh-Manoux A; Dumurgier J;
    Neuroimage; 2022 Apr; 250():118966. PubMed ID: 35122970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.
    Gutiérrez-Galve L; Lehmann M; Hobbs NZ; Clarkson MJ; Ridgway GR; Crutch S; Ourselin S; Schott JM; Fox NC; Barnes J
    Dement Geriatr Cogn Disord; 2009; 28(5):476-85. PubMed ID: 19940480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample.
    Goltermann J; Repple J; Redlich R; Dohm K; Flint C; Grotegerd D; Waltemate L; Lemke H; Fingas SM; Meinert S; Enneking V; Hahn T; Bauer J; Schmitt S; Meller T; Stein F; Brosch K; Steinsträter O; Jansen A; Krug A; Nenadić I; Baune BT; Rietschel M; Witt S; Forstner AJ; Nöthen M; Johnen A; Alferink J; Kircher T; Dannlowski U; Opel N
    Eur Neuropsychopharmacol; 2021 May; 46():93-104. PubMed ID: 33648793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Saeed U; Desmarais P; Masellis M
    Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.